Stockscreener 앱 받기
37.33
1.24%
-0.47
시간 외 거래:
37.33
전일 마감가:
$37.80
열려 있는:
$37.85
하루 거래량:
398.94K
Relative Volume:
1.18
시가총액:
$1.20B
수익:
-
순이익/손실:
$-38.95M
주가수익비율:
-25.13
EPS:
-1.4857
순현금흐름:
$-50.43M
1주 성능:
-12.10%
1개월 성능:
-23.50%
6개월 성능:
+54.19%
1년 성능:
+149.70%
1일 변동 폭
$36.99
$38.57
1주일 범위
$36.99
$43.40
52주 변동 폭
$13.36
$50.16
Lb Pharmaceuticals Inc Stock (LBRX) Company Profile
명칭
Lb Pharmaceuticals Inc
전화
917-450-6581
주소
575 MADISON AVENUE, NEW YORK
Compare LBRX vs VRTX, REGN, MRNA, ARGX, RVMD
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
LBRX
Lb Pharmaceuticals Inc
|
37.33 | 1.20B | 0 | -38.95M | -50.43M | -1.4857 |
VRTX
Vertex Pharmaceuticals Inc
|
526.19 | 133.37B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
788.04 | 81.13B | 14.92B | 4.42B | 3.79B | 41.04 |
MRNA
Moderna Inc
|
198.88 | 79.40B | 2.23B | -3.19B | -1.60B | -8.1462 |
ARGX
Argen X Se Adr
|
959.49 | 60.03B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
204.97 | 43.93B | 742.00K | -1.37B | -1.07B | -7.0731 |
Lb Pharmaceuticals Inc Stock (LBRX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-04-27 | 개시 | H.C. Wainwright | Buy |
| 2026-04-10 | 개시 | Craig Hallum | Buy |
| 2026-01-09 | 개시 | Roth Capital | Buy |
| 2025-10-06 | 개시 | Leerink Partners | Outperform |
| 2025-10-06 | 개시 | Piper Sandler | Overweight |
| 2025-10-06 | 개시 | Stifel | Buy |
모두보기
Lb Pharmaceuticals Inc 주식(LBRX)의 최신 뉴스
LB Pharmaceuticals Inc (LBRX) Stock Price & News - Syfe
LB Pharmaceuticals Inc (NASDAQ:LBRX) Stock Rated "Moderate Buy" by Sell-Side Analysts - MarketBeat
LB Pharmaceuticals at TD Cowen summit: lb-102 aims for safer psychiatry - Investing.com Nigeria
LB Pharmaceuticals rated buy with $85 base value, $150 potential if Phase 3 succeeds by 2027 - Pluang
LB Pharmaceuticals: One Methyl Group, Two Enantiomers, And A Bullish $5 Billion Opportunity - Seeking Alpha
LB Pharmaceuticals Inc (LBRX) Profile, Company FAQs & Facts, Industry, Sector, Employee Strength - Stocktwits
Form 8K LB Pharmaceuticals Inc For: 15 September By Investing.com - Investing.com Australia
LB Pharmaceuticals names Susan Kozauer as chief medical officer By Investing.com - Investing.com Nigeria
LB Pharmaceuticals Names Dr. Susan Kozauer as Chief Medical Officer with Detailed Compensation Package - Kalkine Media
LB Pharmaceuticals names Susan Kozauer as chief medical officer - Investing.com
LB Pharmaceuticals Names Susan Kozauer Chief Medical Officer Ahead of Phase 3 Readout - citybiz
A doctor who helped develop an FDA-approved psychiatric drug joins LB Pharmaceuticals - Stock Titan
LB Pharmaceuticals (LBRX) CFO reports zero share ownership - Stock Titan
Bank of America Corp DE Has $410,000 Stock Position in LB Pharmaceuticals Inc $LBRX - MarketBeat
LB Pharmaceuticals Inc (LBRX) Stock Price, News, Quote & History - Yahoo! Finance Canada
Bank of New York Mellon Corp Makes New $1.78 Million Investment in LB Pharmaceuticals Inc $LBRX - MarketBeat
LB Pharmaceuticals (NASDAQ: LBRX) Names Joseph M. Miller as CFO with $530K Salary and 200,000-Share Stock Option - Kalkine Media
2 Reasons LB Pharmaceuticals (LBRX) Looks Pricey Following Its CFO Appointment - Yahoo Finance
LB Pharmaceuticals to Participate in Upcoming September Investor Events - GlobeNewswire
LB Pharmaceuticals Names Joseph M. Miller as CFO, Details Compensation and Severance Package - Kalkine Media
LB Pharmaceuticals (NASDAQ:LBRX) Stock Price Down 4.3%Here's What Happened - MarketBeat
LB Pharmaceuticals (NASDAQ: LBRX) Appoints Joseph M. Miller as CFO with $530K Salary and Equity Incentives - kalkinemedia.com
LB Pharmaceuticals Inc Announces Appointment of Joseph M. Miller to Chief Financial Officer, Effective September 2, 2026 - marketscreener.com
LB Pharmaceuticals Appoints Joseph Miller as New CFO - TipRanks
LB Pharmaceuticals Appoints Joseph Miller as Chief Financial Officer - The Manila Times
LB Pharmaceuticals Inc (LBRX) Q2 2026 Earnings: Wider-than-Expected Loss Sends Shares Down 3.96%Revenue Guidance Update - careplusvn.com
LB Pharmaceuticals (LBRX) Edges Lower to $47.14 as Support HoldsHull Moving Average - careplusvn.com
LB Pharmaceuticals Inc (NASDAQ:LBRX) Receives Average Recommendation of "Moderate Buy" from Analysts - MarketBeat
HC Wainwright Issues Pessimistic Forecast for LBRX Earnings - MarketBeat
LB Pharmaceuticals (NASDAQ:LBRX) Sets New 52-Week High After Analyst Upgrade - MarketBeat
H.C. Wainwright raises LB Pharmaceuticals price target to $60 By Investing.com - Investing.com India
H.C. Wainwright raises LB Pharmaceuticals price target to $60 - Investing.com
Great Lakes Advisors LLC Purchases Shares of 30,410 LB Pharmaceuticals Inc $LBRX - MarketBeat
LB Pharmaceuticals (NASDAQ:LBRX) Sets New 12-Month HighTime to Buy? - MarketBeat
LB (LBRX) Technical Check: Climbs 1.88% to $47.10 on the Day; Level Position: the $44.74 to $49.46 Range Remains in FocusPositive Gamma - vinanet.vn
LB Pharmaceuticals (NASDAQ:LBRX) Cut to Sell at Wall Street Zen - marketbeat.com
LB Pharmaceuticals (LBRX) investor group reports 5.0% beneficial stake in 13G/A - Stock Titan
Stifel raises LB Pharmaceuticals stock price target on pipeline outlook By Investing.com - Investing.com South Africa
Stifel raises LB Pharmaceuticals stock price target on pipeline outlook - Investing.com
Stifel Maintains LB Pharmaceuticals(LBRX.US) With Buy Rating, Raises Target Price to $53 - Moomoo
LB Pharmaceuticals (LBRX) Slips 2.45% as Key Support Levels Come into FocusOversold Bounce Ideas - dars.gov.et
LB PHARMACEUTICALS INC : LEERINK PARTNERS RAISES TARGET PRICE TO $55 FROM $40 - webull.com
LB Pharmaceuticals Inc Common Stock (NASDAQ: LBRX) Stock Price, News & Analysis - Kalkine
BMO Capital Markets Increases LB Pharmaceuticals (NASDAQ:LBRX) Price Target to $54.00 - MarketBeat
LBRX SWOT Analysis: Key Insights from 10-Q Filing - GuruFocus
Form 8K LB Pharmaceuticals Inc For: 11 August - Investing.com India
LB Pharmaceuticals Inc Stock 12‑Month Price Target Raised to $47.67, Implies 4% Upside - TradingView
LB Pharmaceuticals Submits Q2 2026 SEC Form 10-Q Reporting 32.26M Shares Outstanding - Kalkine Media
LB Pharmaceuticals2026 Funding Rounds & List of Investors - tracxn.com
LB Pharmaceuticals Releases Q2 2026 Financial Results - AlphaStreet
Form 8K LB Pharmaceuticals Inc For: 11 August By Investing.com - Investing.com Nigeria
Lb Pharmaceuticals Inc (LBRX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
3.06%
2.55%
자본화:
|
볼륨(24시간):